After 35 years of AIDS, it's time our voice is heard
HIV stands for human immuno-deficiency virus. AIDS stands for acquired immune deficiency syndrome.
HIV is transmitted through blood, semen, vaginal secretion, and breast milk. You can become infected with HIV in the following ways:
Stigma and discrimination are the main reasons people resist getting tested, which leads to late diagnoses and a greater chance for HIV to progress to AIDS, making treatment less effective and increasing the likelihood of transmission to others. People who have experienced stigma are four times more likely to report poor access to care. Stigma also affects the emotional well-being of those with HIV, as it leads to loss of hope and feelings of worthlessness.
Standard AR therapy consists of a combination of at least three AR drugs that work to suppress the virus and stop the progression of the disease.
Side effects can include nausea, vomiting, bleeding events, diabetes, cardiovascular disease, and toxic epidermal necrosis. If you or someone you know is taking ARs and experiencing side effects, talk to your doctor to figure out the best treatment plan.
People are resistant to HIV if they have a natural genetic mutation on their cells that doesn't allow HIV to latch on.
The cure method used for the Berlin Patient would involve a stem cell transplant. Since stem-cell transplants can cost up to $250,000 and is not viable for many people, the Delta 32 mutation would have to be given without a transplant. This means the Delta 32 mutation would have to be created, instead of donated.
It is extremely rare to find someone who is a bone marrow match and rarer still to find someone who is also HIV-resistant. Therefore, the Berlin Patient’s procedure method is not broadly applicable. This is why our Chromovert® technology is so important in creating curative stem cells, alleviating the need to find rare matches.
Chromovert® is a proprietary cellular technology that can isolate and enrich rare cells with optimal, desired genetics. It has successfully isolated cells that mimic human taste buds for leading food companies like Coca-Cola®, Nestle®, and Kraft®, as well as pain-blocker cells that allowed the discovery of new drugs that surpass the effects of morphine. It is now being used to create the Delta 32 mutation, which would give rise to an HIV-resistant immune system, ultimately curing the person of AIDS.
RFTCA President Kambiz Shekdar realized that the biotechnology he invented called Chromovert® Technology can create curative stem cells and replicate the cure used on the Berlin Patient, the only person cured of AIDS. Once Kambiz realized his technology may hold the keys to a cure, he sought out organizations and experts that could help him achieve it.
We welcome people from all walks of life to help us in our cause for a cure. Go to the Get Involved page to donate, volunteer, and share your story.
An alliance such as ours reflects diverse thinking and experiences. We believe we need experts from scientific, clinical, manufacturing, medical, legal, financial, philanthropic, creative, artistic, and other areas in order to succeed. We welcome those living with AIDS, taking care of someone with AIDS, or affected by AIDS in some other way to take a seat at the table and join us. We need to hear stories from different people from all walks of life to make the most meaningful impact.
Greg, one of my best friends from childhood, was diagnosed with HIV when we were around 19 years old. Living in an uppity suburb of New Jersey, HIV was rarely spoken of. And AIDS was no longer seen as a death sentence by that time, so I hardly gave much thought to the virus. Growing up, we were taught that HIV was contracted only by gay or poor people. I was about as concerned with HIV as I was with Ebola or some other “rare” or “exotic” illness, so Greg’s diagnosis was a huge shock and brought my perception of HIV down to earth. He was exceptionally secretive about his HIV status. The shroud he and his family placed around his illness added a sense of shame to it—as if he had some fault in contracting the disease. Greg started taking medication, and the sense of urgent concern started to neutralize over time. I asked him about how he managed his disease. Did he ever skip his meds? Did he experience side effects? When did he tell his sexual partners he was positive? Did he always use a condom? Did he only have sex with other positive people? His answers were, respectively: no; not really; only before anal intercourse, and not all the time since he was “undetectable”; not always; and not necessarily. It seemed the initial stigma-fueled alarm and secrecy faded as he grew more confident in his treatment. He became more relaxed about his infection, and so did I. For Greg, for the sake of those living without access to treatment, and for those who will be infected in the future with new, possibly more virulent strains of HIV, a true cure is needed. This demand for a cure and the associated cure method the RFTCA is pursuing is what we need today in 2016 and beyond.
If you have a question or comment, please write to us using the contact information below. We'd love to hear from you.
Research Foundation to Cure AIDS
c/o Christian Kopfli
44 Gramercy Park North
New York, NY 10010